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Abstract
Background: It has been proposed that the use of gene expression microarrays in nonrecombinant parental or
congenic strains can accelerate the process of isolating individual genes underlying quantitative trait loci (QTL).
However, the effectiveness of this approach has not been assessed.
Results: Thirty-seven studies that have implemented the QTL/microarray approach in rodents were reviewed.
About 30% of studies showed enrichment for QTL candidates, mostly in comparisons between congenic and
background strains. Three studies led to the identification of an underlying QTL gene. To complement the literature
results, a microarray experiment was performed using three mouse congenic strains isolating the effects of at least
25 biometric QTL. Results show that genes in the congenic donor regions were preferentially selected. However,
within donor regions, the distribution of differentially expressed genes was homogeneous once gene density was
accounted for. Genes within identical-by-descent (IBD) regions were less likely to be differentially expressed in
chromosome 2, but not in chromosomes 11 and 17. Furthermore, expression of QTL regulated in cis (cis eQTL)
showed higher expression in the background genotype, which was partially explained by the presence of single
nucleotide polymorphisms (SNP).
Conclusions: The literature shows limited successes from the QTL/microarray approach to identify QTL genes. Our
own results from microarray profiling of three congenic strains revealed a strong tendency to select cis-eQTL over
trans-eQTL. IBD regions had little effect on rate of differential expression, and we provide several reasons why IBD
should not be used to discard eQTL candidates. In addition, mismatch probes produced false cis-eQTL that could
not be completely removed with the current strains of genotypes and low probe density microarrays. The
reviewed studies did not account for lack of coverage from the platforms used and therefore removed genes that
were not tested. Together, our results explain the tendency to report QTL candidates as differentially expressed
and indicate that the utility of the QTL/microarray as currently implemented is limited. Alternatives are proposed
that make use of microarray data from multiple experiments to overcome the outlined limitations.
Background
The study of genetics of quantitative traits has benefited
from the availability of new technologies that generate
massive information at the genomic and transcriptomic
levels [1]. Microarray technology has been recognized as
a powerful tool that could aid in the identification of
the genes underlying quantitative trait loci (QTL; [2,3]).
Microarray data can be analyzed within a QTL context
following a genetical genomics (GG) approach [4]. This
methodology considers gene expression values as a
quantitative trait that can be mapped to chromosomal
locations in a segregating population. Such genomic
positions are called expression QTL (eQTL), which can
be either cis-o rtrans-acting modifiers of gene expres-
sion, depending on whether they are located in the vici-
nity of or far from the measured gene, respectively. In
practice, the validity of this distinction depends on the
resolution of the QTL analysis, i.e., the density of the
genetic map and the size of the segregating population
[5]. Here we refer to QTL for phenotypes other than
gene expression as pQTL to differentiate them from
eQTL.
Some general ideas on eQTL can be drawn from rele-
vant GG studies. Experiments in yeast [6], maize and
mouse [7], and humans [8] found that most transcripts
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for less than one third of parental expression differ-
ences. eQTL with the largest effects are located in close
proximity to the target gene (within 10 Kb in yeast and
within 1 Mb in mice and humans), which are referred
to as proximal or cis eQTL [6,7]. However, most of the
detected eQTL have been found to be trans-acting. The
overall distribution of eQTL along the genome reveals
t h ep r e s e n c eo f“hot spots” with trans-eQTL for a large
number of genes genome-wide [9]. These hubs of trans-
eQTL do not necessarily represent transcription factors,
but more likely represent a heterogeneous group of
transcription regulators [10] or could simply be the
result of unaccounted for nongenetic correlation among
transcripts [11]. When real, trans-eQTL hot spots can
be used to identify gene modules under common
genetic regulation [12]. Their detection, however,
requires a larger sample size than typical GG studies
provide; hence, they are missed in smaller-scale designs
[9,13,14]. cis-e Q T La r eu n i q u eb ys o m ed e s i r a b l ep r o p -
erties, e.g., (1) known location of the causal gene and (2)
their effect sizes are usually large and can be detected
with smaller sample sizes. In general, cis-eQTL are
regarded as strong quantitative trait gene (QTG) candi-
dates when they are located under pQTL, their expres-
sion is correlated with the phenotype, and they tend to
be located in regions not involved in identity-by-descent
(IBD) relationships [15-17]. However, the cost of large-
scale microarray profiling of a segregating population
restricts the application of the GG approach. Therefore,
experimental designs requiring a lower number of
microarrays for the identification of cis-eQTL are
desirable.
An alternative approach is defined in this paper as the
QTL/microarray approach. This approach refers to the
combined use of traditional QTL mapping and subse-
quent microarray profiling of nonrecombinant parental
or congenic strains to reduce the number of candidate
genes in QTL regions [18-20]. The methodology used in
QTL/microarray studies, even though it varies among
researchers, shares some common procedures that can
be summarized as follows: (1) QTL mapping experiment
and identification of genes located within confidence or
support intervals for QTL, (2) a test of differential
expression between parental strains (Parental design),
(3) cross-reference list of positional candidates from
step 1 and expression candidates from step 2, (4)
hypothesis- or knowledge-driven filtering of the list of
candidates, (5) independent confirmation of differential
expression, and (6) experimental validation of causative
genes. Step 3 sometimes compares gene expression on
congenic and background strains (Congenic design) or
between animals with extreme phenotypes from a segre-
gating population (Extremes design). Step 5 often
involves measuring expression of candidate genes by
qRT-PCR in an independent set of samples, but can also
involve Northern or Western blot analysis. Step 6 is
usually part of a separate project that follows a QTL/
microarray study.
The rationale behind QTL/microarray studies is that
causative genes may have polymorphisms causing differ-
ences in their level of expression that translate into
varying amounts of mRNA and ultimately varying
amounts of functional proteins, leading to observable
phenotypes. There are several mechanisms by which a
QTG could change gene expression levels. A mutation
in the binding site for a transcription factor may, for
instance, decrease its binding affinity to the ligand,
affecting the gene’s transcription level [21]. Mutations in
the transcription factors themselves could also affect
recognition of their targets, thus also changing the
gene’s transcription level. Likewise, nonsense mutations
in the coding sequence of a gene can decrease transcript
levels by nonsense-mediated decay [22].
In contrast to the GG approach, transcript profiling of
nonrecombinant animals does not allow QTL mapping
of the expression levels and therefore cannot differenti-
ate between cis-a n dtrans-eQTL. However, co-localiza-
tion of a differentially expressed gene and the pQTL can
be tested, given that a physical, or genetic, map is avail-
able for the genes. This would be equivalent to a cis-
eQTL/pQTL co-localization test for the genes under cis
control. An approach for sorting out cis-f r o mtrans-
eQTL in this experimental design consists of first isolat-
ing the genomic region with the pQTL in a congenic
strain by backcrossing a donor strain to a recipient
strain for multiple generations and then testing differen-
tial gene expression between the congenic and the reci-
pient background strain. Depending on the size of the
congenic strain, differentially expressed genes in the
d o n o rr e g i o na r el i k e l yt ob eu n d e rcis regulation or
alternatively by trans control from linked genes within
the limits of the congenic interval. In contrast, differen-
tial expression of genes outside the donor region is
expected to be regulated, directly or indirectly, by genes
located within the congenic interval. Contaminating
donor DNA in places outside the congenic donor region
could produce false trans-eQTL. However, nonrecombi-
nant individuals from an F2 cross between the congenic
and background strains can be used to randomize the
effect of contaminating regions.
The QTL/microarray approach is not exempt from
issues that need to be addressed. A well-known problem
associated with these studies is that DNA polymorph-
isms can affect the binding of microarray probes and
significantly decreasing detectable signals. Such artifacts
can produce an increase in false-positive results when
genetically divergent individuals are compared with
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only issue that may affect QTL/microarray results.
Despite the wide use of the approach, no systematic eva-
luation of its performance has been reported.
In the current paper, a critical study of the QTL/
microarray approach applied to the analysis of complex
traits with clinical relevance in humans was performed.
First, the literature was reviewed and a meta-analysis of
rodent studies that have implemented this approach was
conducted. Second, a microarray experiment with three
mouse congenic strains was designed to test whether
differential expression is associated with QTL peaks.
The advantages and limitations of the QTL/microarray
approach are discussed, and recommendations for the
effective use of microarrays for the dissection of com-
plex traits are provided.
Results and Discussion
Literature review
Thirty-seven published studies using the QTL/microar-
ray approach in rats (Table 1) or mice (Table 2) were
examined for key features of their experimental design.
Most of the microarrays used were whole-genome
arrays, including both cDNA, especially for older stu-
dies, and oligonucleotide arrays. Although the objective
of using microarrays in most of these studies was simi-
lar, i.e., identification of differentially expressed genes
under pQTL peaks, the methodologies used varied
greatly. Particularly, no standards were followed in the
statistical methodologies used for testing differential
expression. Some studies do not report the methodology
used at all [25,26]. Others report from one to three
sequentially applied criteria to select lists of differentially
expressed genes, which varied in nature and in statistical
support. For instance, arbitrary thresholds by absolute
intensity difference or fold changes (FC) [27-33], differ-
ent combinations of FC and t-statistics [34-36], ranking
by FC and selecting only the top 100 most significant
genes [37], correlation to a hypothetical constant gene
[38], and concordance in FC direction across experi-
mental groups [39], among others (for the complete list
studies with details about experimental design, see Addi-
tional file 1). Although applying multiple criteria can be
attractive in terms of reducing the number of candi-
dates, this is likely to reduce power in an unpredictable
manner. This is further complicated when a criterion
such as fold change (FC) is used, which has unknown
significance level.
In some cases, the QTL/microarray design has led to the
identification of a QTG. In rats, two studies were identi-
fied confirming the role of QTGs, i.e., Cd36 in insulin
resistance [27] and Klk1 in hypertension [31]. Using a
cDNA microarray, the Cd36 gene was selected as differen-
tially expressed in adipose tissue between two divergent
inbred strains of rats as well as between a congenic strain
isolating a QTL on chromosome 4 and the background
strain. This gene was located within the limits of the con-
genic donor region, but it was not mentioned whether
Table 1 Published studies analyzing parental strains using the QTL/Microarray approach in rat
Phenotype QTL Mapping Microarray Experiment References
Design Strains Design Tissues Platform
Targeted custom arrays
Hypertension Congenic DS, LEW Congenic Kidney Custom/
TIGR
[43]
Hypertension F2 DS, LEW Parental Kidney RT-PCR [31]
Whole-Genome arrays
￿ Aerobic running capacity Congenic DS, DR Parental Kidney RGU34 [34,95,96]
Alcohol addiction Congenic iP, iNP Congenic NAC, FC, ABR, hippocampus, striatum RG230v2 [97]
Hypertension F2 SBH/y, SBN/y Parental Kidney RAE230 [41,98]
￿ Hypertension Congenic DS, LEW Congenic Kidney RGU34 [30]
￿ Hypertension Congenic DS, DR Congenic Kidney RGU34 [42,99]
￿ Hypertension Congenic SHRSP, WKY Congenic Kidney RGU34 [44]
Hypertension F2 DS, LEW Parental Kidney RAE230 [32]
Hypertension F2 DS, LEW Parental Kidney, adrenal gland, liver, brain RG230v2 [33]
￿ Kidney stones Congenic GHS, WKY Congenic Kidney, SI, FOC RAE230 [37]
Metabolic syndrome Congenic SHR, WKY Congenic EWAT Spotted [27]
Hypertension Congenic DS, DR Parental Kidney GF 300 [40]
Tissue abbreviations: ABR: amigdala brain region, EWAT: Epididymal white adipose tissue, FC: frontal cortex, FOC: femoral osteoclast cells, NAC: nucleus
accumbens, SI: small intestine. Strain abbreviations: DS: Dahl salt-sensitive, DR: Dahl salt-resistant, GHS: genetic hypercalciuric stone-forming, iP: alcohol non-
preferring, LEW: Lewis rats, P: alcohol preferring, SHR: spontaneously hypertensive rat, SHRSP: stroke-prone spontaneously hypertensive rat, SBH/y: Sabra salt-
sensitive hypertensive, SBN/y: Sabra salt-resistant normotensive, WKY: Wistar Kyoto.
￿ Articles included in Table 3.
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[27]. This finding suggested Cd36 as a candidate asso-
ciated with insulin resistance syndromes. Northern blots
and sequencing revealed that the microarray probe target-
ing the 3’ end of the mRNA molecule detected alternative
splicing of the last exon and not differential expression.
This was translated into absence of protein levels in
plasma, and a transgenic model confirmed the effects of
Cd36 on lipid levels in the blood [27]. It was not
mentioned by Atiman et al.[ 2 7 ]h o wm a n yg e n e sw e r e
located within the congenic region, presumably because it
was not known at the time of publication, when a physical
map of the rat genome was not available. Unfortunately,
t h ei d e n t i t yo ft h em i c r o s a t ellite markers defining the
donor region was not provided, and it was not possible to
calculate the size of the region. For this reason, the study
by Aitman et al. [27] was not included in the meta-analysis
in Table 3.
Table 2 Published studies analyzing parental strains using the QTL/Microarray approach in mouse
Phenotype QTL Mapping Microarray Experiment References
Design Strains Design Tissues Platform
Targeted custom arrays
Arthritis Congenic RIIIS/J, B10.RIII Congenic Lymph nodes,
spleen, paws
Custom [100]
Obesity Congenic SPRET/Ei, C57BL/6J Parental Brain, EWAT, GSM,
liver
Nimblgen [101]
Whole-Genome arrays
￿ Alcohol
addiction
RIL HAFT, LAFT Parental Brain MGU74A [39,102]
￿ Alcohol
addiction
RIL C57BL/6J, DBA/2J Parental NAC, PFC, VTA U74Av2 [103]
Alcohol
addiction
Congenic ISS.ILS.Lore, ISS Parental CR MO430A, MOE430B [38,104]
￿ Anxiety Knockout/
congenic
B6.129-Il10-/-, C57BL/6J Congenic ABR MOE430 [105]
Anxiety Database - Parental PFC, VS, TL, PG, CR Spotted [106]
￿ Arthritis AIL DNA/1J, FVB/N Parental Lynph nodes MOE430A [107]
Arthritis AIL DNA/1J, FVB/N Parental Lynph nodes U430A [36]
￿ EIAD F2/RIL DBA/1, C57BL/6J Extremes Lung NIA15k [52]
￿ Gallstones BC C57L/J, AKR/J Parental Liver Spotted [108,109]
￿ HSCP RIL, BC,
Congenic
C57BL/6J, DBA/2J Parental HSC Filter [49]
￿ IBD BC B6-Il10
-/-, C3H-Il10
-/- Congenic Colon U74Av2 [35,110]
Lung injury
response
BC A/J, C57BL/6J Parental Lung Spotted [29]
￿ Macronutrient
intake
Congenic C57BL/6J, CAST/EiJ Congenic Liver,
hypothalamus
ABI [103]
￿ Obesity Congenic F-line, L-line Congenic Liver, BAT Spotted [111]
￿ Obesity BC C57BL/6J, SPRET/Pt, SPRET/Ei Extremes EWAT Spotted [112]
￿ Obesity F2 DU6i, DBA/2 Parental EWAT Mu11k [47]
￿ Osteoporosis Congenic C57BL/6J, CAST/Ei Congenic Femur Spotted [28,113]
Osteoporosis RI C57BL/6J, CAST/Ei Parental Kidney Spotted [26,45]
Platelet count F2 CBA/CaH, QSi5 Parental Liver, kidney,
spleen
Spotted/Compugen
Mouse 22K
[25]
￿ Pulmonary
capacity
F2/BC C3H/HeJ, JF1/Msf Parental Lung Spotted/Operon [114]
TR BC/
Introgression
A/J, C57BL/6J Parental Liver, kidney,
spleen
MG-430v2 [96,115]
￿ Type I
diabetes
Congenic NOD, Idd3, Idd5, Idd3+5, Idd9, B10, B10.
H2g7, B10.H2g7Idd3
Congenic Thymus, Spleen Affy.Eos.Custom [116]
Phenotype abbreviations: EIAD: Endotoxin-induced airway disease, HSCP: Hematopoietic stem cells proliferation, IBD: Inflammatory bowel disease, TR:
Trypanosomiasis resistance. Tissue abbreviations: ABR: amigdala brain region, BAT: Brown adipose tissue, CR: cerebellum, GSM: gastrocnemius skeletal muscle, HSC:
Hematopoietic stem cells, NAC: nucleus accumbens, PFC: Prefrontal cortex, PG: periaqueductal gray, TL: temporal lobe, VS: ventral striatum, VTA: ventral
tegmental area. Strain abbreviations: HAFT: High Acute Functional Tolerance, ILS: Inbred Long Sleep, ISL: Inbred Short Sleep, LAFT: Low Acute Functional
Tolerance. ￿ Articles included in Table 3.
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used to study hypertension. A total of nine studies were
identified that compared gene expression between rat
strains that showed spontaneous difference for blood
pressure [31-33,40,41] or between congenic and back-
ground strains created from these lines [30,42-44]. These
studies have led to the direct identification of as many as
50 candidate genes for hypertension and to the confirma-
tion of at least one causal gene, namely, Klk1 [31].
Instead of microarrays, Iwai et al. [31] used real-time
polymerase chain reaction (PCR) to test 399 transcripts
located within the confidence interval for the QTL posi-
tion. It was reported that among 240 transcripts that
were detected in kidney tissue, two were differentially
expressed, i.e., Klk1 and Ngfg.F r o mt h e s e ,o n l yKlk1 was
confirmed by Western blot analysis [31]. The role of Klk1
as a QTG was confirmed by alleviation of hypertension
symptoms through adenoviral transfer of human Kallik-
rein 1. Because expression profiling was restricted to the
target region of the QTL, this study was not included in
the overrepresentation test in Table 3.
Among the mouse studies reviewed, one QTG was
identified using the QTL/microarray approach, i.e.,
Alox15. Klein et al. [26] generated a congenic strain to
isolate a QTL for peak bone mineral density on mouse
chromosome 11 that was previously identified by Klein
et al. [45]. This was followed by measuring gene expres-
sion in kidney tissue using a whole genome high-density
a r r a y( s e eT a b l e2 ) .Alox15 was the only gene reported
as being differentially expressed in the congenic region
between the strains. This was confirmed by qRT-PCR in
kidney and osteoblast cell cultures. Furthermore, the
role of Alox15 was confirmed by a complementation
test with an Alox15
-/- k n o c k o u tm o u s ea sw e l la st w o
drugs that inhibit the protein product coded by this
gene [26]. There are over 2500 genes known in the
donor region for the congenic strain, so as in previous
examples, after QTL mapping, microarray testing was
the single step that reduced the number of candidate
g e n e st h em o s t .U n f o r t u n a t e l y ,i tw a sn o tr e p o r t e dh o w
many genes were differentially expressed genome-wide,
and therefore this study also had to be excluded from
our tests in Table 3.
Meta-analysis
Because of missing information, statistical testing could
be performed on only 20 of the 37 studies compiled
(Table 1 and Table 2). In addition, microarrays do not
cover all genes in the genome [46]. To control for the
differences in the level of genome coverage between
platforms used in each study, the meta-analysis was per-
formed using two reference sets: genes in the genome
and probes in the microarray (see Methods). Filtering by
differential expression, on average, selected 1.9% of
pQTL candidates’ genes (range from 0% to 15%; Table
3). Of 20 publications with sufficient information, 6
(30%) reported differentially expressed genes that were
significantly enriched and 3 (15%) studies were underre-
presented for genes within the pQTL or congenic region
when compared with the whole genome (P <0 . 0 5 ) .
When using probes in the array as a reference, 7 (35%)
were overrepresented and 7 (35%) were underrepre-
sented (Table 3). The four experiments that were under-
represented for candidates only when using genes in the
microarray as reference were performed on microarrays
with low genome coverage (13K, [47], 12.5K, [35,48]) or
on filter arrays [49]. Because the number of pQTL can-
didates represented in the microarrays was not available,
we used the total number of genes under QTL intervals
as an approximation. Low genome coverage produced
overestimation of the true number of tested candidates,
explaining their apparent underrepresentation among
differentially expressed genes in these platforms.
The number of tests for differential expression applied
in each study was used to question whether increasing
the number of selection criteria increases the probability
of selecting QTL candidate genes. No such trend was
observed. In fact, the largest enrichments were seen in
studies using a single selection criterion (Figure 1).
When divided by type of experiment, only one of eight
Parental comparisons revealed enrichment for candidate
genes. This is not unexpected, given that the test was
performed not on QTG but only on positional candi-
dates. Furthermore, inbred strains can present genome-
wide genetic divergence that is not related to the speci-
fic phenotype under study. This limitation of the Paren-
tal design can be alleviated with the comparison of
Extremes, where animals are specifically selected for the
phenotype of interest and regions not harboring QTL
are expected to segregate randomly relative to the phe-
notype. The Extremes d e s i g ni st h eg e n ee x p r e s s i o n
equivalent of mapping by allelic association where mar-
ker genotype frequencies are compared instead [50]. In
both types of comparison, the degree to which differ-
ences between extremes are informative about an under-
lying association with the phenotype depends on the
population and sample sizes, range of linkage disequili-
brium (LD), and population history and structure; there-
fore, proper experimental design is required to avoid
spurious associations [51]. Of two studies reviewed of
this type, one presented significant enrichment. How-
ever, the one that showed significance used a modified
design where the two extreme groups were composed of
one parental strain and one recombinant inbred line
[52]. Because of the confounding of two designs, i.e.,
Parental and Extremes, and its small sample size [only
one recombinant inbred line (RIL) per extreme group],
no further interpretation of this result is attempted. In
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studies with sufficient information for meta-analysis. Of
these, five studies revealed enrichment for candidate
genes. By design, only regions that are confirmed to har-
bor QTL have genetic divergence, and therefore enrich-
ment of QTL candidates can be expected. However,
multiple factors can potentially contribute to this trend.
Polymorphic genomic regions are more likely to host
pQTL for any trait and to generate allelic bias in probe
binding for one strain versus the other. This situation
can be expected in cases where the microarray has been
designed for one of the strains that are being compared,
or for a strain that is genetically more closely related to
one of them. Allelic bias of probe binding will have a
systematic effect on fluorescence intensity levels, which
can be interpreted as differential gene expression. Since
higher polymorphism rate is expected to increase both
frequency of QTL as well as allelic bias of probe signals,
the variables would be associated and the observed over-
representation of pQTL candidates may result from
such confounding effect. Both hypotheses are not
mutually exclusive, since in reality QTL regions may be
enriched for both polymorphisms that produce allelic
bias as well as for functional polymorphisms that pro-
duce differential expression. However, it is important to
assess the relative importance of these two factors in the
apparent tendency for some QTL/microarray experi-
ments to report pQTL candidates as differentially
expressed.
Meta-analysis of results from the literature presents
several limitations. Overrepresentation of pQTL candi-
dates can be affected by a number of factors, such as
Table 3 Overrepresentation test for pQTL candidate genes in lists of differentially expressed genes in QTL/microarray
experiments
a
Phenotype pQTL genes Microarray Experiment Selected Genes Genome Microarray References
Platform Probes GW QTL OR P OR P
Rat
Congenic
Hypertension 198 RGU34 26379 45 3 8.15 0.007 9.57 0.005 [44]
Hypertension 267 RGU34 26379 27 0 0.00 1.0 0.00 1.0 [30]
Hypertension 78 RGU34 26379 20 1 15.31 0.067 17.95 0.058 [42,99]
Kidney stones 551 RAE230 31042 50 16 19.27 3.1e-14 26.76 2.2e-16 [37]
Parental
Aerobic running capacity 467 RGU34 26379 199 9 2.26 0.024 2.66 0.009 [34,95,96]
Mouse
Congenic
Anxiety 187 MOE430 45037 9 3 17.60 0.062 30.12 0.037 [105]
IBD 5541 U74Av2 12488 94 16 0.77 0.377 0.26 2.6e-08 [35,110]
Macronutrient intake 1230 ABI 32991 3101 185 1.35 3.9e-04 1.75 1.4e-10 [103]
Obesity 503 Spotted 14938 13 1 4.30 0.221 2.39 0.359 [111]
Osteoporosis 27 Spotted 8734 283 1 3.56 0.253 1.15 0.59 [28,113]
Type I diabetes 1294 Affy.Eos Custom 39000 170 17 2.17 0.006 3.27 5.6e-05 [116]
Parental
Alcohol addiction 3251 MGU74Av2 12488 169 6 0.26 1.4e-04 0.10 6.3e-15 [39,102]
Alcohol addiction 4423 U74Av2 12488 996 151 0.88 0.18 0.30 1.5e-49 [48]
Arthritis 649 MOE430A 22000 1396 18 0.50 0.002 0.41 3.9e-05 [107]
Gallstones 416 Spotted 8734 57 0 0.00 1.0 0.00 0.114 [108,109]
HSCP 867 Filter 5184 200 11 1.72 0.105 0.28 1.6e-06 [49]
5079 Mu11k 13069 77 14 0.93 0.886 0.35 1.4e-04 [47]
Pulmonary capacity 1261 Spotted/Operon 31775 933 1 0.02 4.9e-19 0.03 2.0e-15 [114]
Extremes
EIAD 460 NIA15k 15000 30 0 5.59 4.8e-12 3.10 9.3e-07 [52]
Obesity 1610 Spotted 11000 50 5 1.71 0.23 0.65 0.427 [112]
Phenotype abbreviations: EIAD: Endotoxin-induced airway disease, HSCP: Hematopoietic stem cells proliferation, IBD: Inflammatory bowel disease.
aNumber of pQTL candidate genes was extracted from references or calculated from UCSC Genome Browser within the limits of the pQTL confidence intervalso r
congenic donor regions. Selected Genes columns indicate number of differentially expressed genes genome-wide (GW) or in candidate regions (pQTL). OR
columns denote the ratio of odds, i.e. fraction of candidate genes in the selected and in the references sets. P-values (P) for over- (OR > 1) or under-
representation (OR < 1) of QTL candidate genes in list of selected genes were calculated using the genome and microarray probes as reference (see methods).
Significant p-values (P < 0.05) are shown in bold.
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or that are located near pQTL and inaccurate estimation
of the gene coverage in microarrays. The number of
candidate genes that were targeted by each microarray
was largely unknown and the two reference sets used, i.
e., total number of genes in the genome and number
probes in the microarray, may not be optimum refer-
ence sets for overrepresentation tests. Furthermore, het-
erogeneity in quality of microarray annotation,
definition of candidate region limits, and statistical pro-
cedures for data processing and differential expression
testing limit our ability to investigate the specific causes
of enrichment for pQTL candidates in their results.
Therefore, an in-house microarray experiment was
deemed necessary to specifically test for overrepresenta-
tion of candidate genes among differentially expressed
genes. This gave us complete control over all these vari-
ables and allowed performing more specific tests that
considered probe mismatches, IBD regions, and QTL
location within congenic donor regions.
Experiment using three congenic strains
Differential expression between three CAST.C57.hg
-/-
mouse congenic strains with their genotypic background
controls C57.hg
-/- was tested on the Illumina Mouse-6
microarray with samples from brain, liver, and gonadal
white adipose tissue (see Methods; data available at the
NCBI GEO repository by accession GSE22042). This
platform has coverage for 71.7% of 30,388 EntrezGenes
in the mm9 genome assembly and for 75.5% of Entrez-
Genes in the donor region of the congenic strains. Dif-
ferential expression analysis detected a total of 577, 110,
and 109 genes (targeted by 682, 131, and 148 probes)
genome-wide that were affected by allelic variants of
genes in the congenic region of HG2D, HG11, and
HG17, respectively. Of these, 124, 89, and 95 genes
were located within the donor regions of those strains.
Probes selected within the donor regions presented an
allelic bias toward higher intensity of the C57 samples
(Figure 2a). Since the reference mouse genome sequence
used to design the microarray probes is C57, poly-
morphisms between this strain and CAST may have an
effect on the binding affinity of microarray probes. A
total of 410 probes overlapped at least one of the
289,541 known or imputed single nucleotide poly-
morphisms (SNP) within the limits of the donor regions
(31 probes had two SNP, and one probe had three
SNP). Of these, 209 probes detected a transcript in at
least one tissue. This is in agreement with an observed
bias toward higher intensity from C57 alleles in probes
with known or imputed SNP (Figure 2b). However, alle-
lic bias for genes in the donor region persisted even
after these probes were removed (Figure 2c), suggesting
that many SNP between C57 and CAST may still be
unknown. However, it is also possible that the allelic
bias is reflecting functional polymorphisms that can be
detected in only one direction. For instance, insertions
in the CAST genome would not be detected, whereas
insertions in the C57 genome are detected as deletions
in the CAST genome. Likewise, nonsense mutations
causing RNA decay will only be apparent in CAST,
since probes were designed for C57 mRNA molecules.
On the basis of these findings, we recommend the use
of high-density microarrays that target mRNA molecules
in multiple locations, and custom probeset definitions
can be designed to target only perfect matching
sequence in the particular cross under study. The
absence of this or alternative techniques [23] in all the
reviewed papers leads us to conclude that such probe-
binding artifacts also explain, at least in part, the
increased frequency of candidate genes among reported
differentially expressed genes.
Differential expression testing reduced the number of
positional candidates from 1596, 1132, and 1347 to 124,
89, and 95 genes, that is, a reduction in 92.2%, 92.1%,
and 92.9%, for HG2D, HG11, and HG17, respectively.
However, these apparently high filtering rates result not
only from lack of differential expression but also from
lack of expression, removal of probe due to SNP, and
lack of coverage of the microarray. Because untested
Figure 1 Odd ratio for QTL candidates in list of differentially
expressed genes. Odds ratios for the enrichment of candidate
genes in lists of differentially expressed genes versus all genes in
the microarray (see Methods) is plotted versus number of selection
criteria used by authors to reduce the number of selected genes.
Studies are colored by type of microarray comparison: congenic vs.
background strains (Congenic), parental inbred strains of the cross
that was used for QTL mapping (Parental) or recombinant inbred
lines (RIL). See Additional file 1 for details about the selection criteria
used in each study.
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were targeted only by SNP-overlapping probes or not
targeted at all in the microarray must be added back to
the list of potential candidates. These represent 29%,
22.6%, and 33.2% of genes in the chromosomes 2, 11,
and 17 donor regions, which were excluded from differ-
ential expression testing. The 124, 89, and 95 differen-
tially expressed genes plus the 463, 256, and 447 genes
that were not tested leaves a total of 587, 345, and 542
genes that would need further testing in each of the
H2D, HG11, and HG17 congenic regions. The effective
reduction of candidates by differential expression testing
after adjustment was 63.2%, 69.5%, and 59.8%, respec-
tively, i.e., 64% on average.
All differentially expressed genes located outside
donor regions can be considered under trans regulation,
Figure 2 Allelic bias in probe-level intensity. Fold change for average intensity from samples of the C57 background genotype over the
average from samples of the CAST congenic genotype is shown in log2 scale for congenic strains in chromosomes 2 (HG2D), 11 (HG11) and 17
(HG17). (a) Probes are separated by genomic location for genes within donor congenic region and genes in the background genome. (b) Probes
are separated in to those that overlap at least one known SNP (has SNP) from those that do not (no SNP). (c) Plots in (a) after removing probes
in donor region with SNP. P values for difference between groups are shown above each graph.
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in trans were observed in almost every chromosome in
the genome (Table 4). Differentially expressed genes
within the congenic regions are candidates for cis-eQTL
regulation and represented 21.5%, 80.1%, and 87.2% of
s e l e c t e dg e n e s ,w h i c hi sh i g h l yu n l i k e l yb yc h a n c ec o n -
sidering that only 5.2%, 4%, and 4.2% of genes in the
array are located in each of these regions (P =6 . 3 8×
10
-43, P = 1.11 × 10
-104, and P = 4.24 × 10
-117) for chro-
mosomes 2, 11, and 17, respectively. This high cis-eQTL
enrichment was observed despite the fact that probes
overlapping known SNP between CAST and C57 gen-
omes were removed. Furthermore, some genes classified
as trans r e g u l a t e dl a yr i g h ta tt h ee n d so ft h ec o n g e n i c
regions and are most likely cis regulated (Figure 2). This
is expected because the limits for the donor regions
used here represent minimum intervals from low-den-
sity genotyping [53], and the true limits may extend
further than these intervals. We observed an approxi-
mate 3.1 to 1 ratio between cis and trans eQTL. It has
been argued that selection acts distinctively on cis eQTL
owing to quantitative effects, limited pleiotropy, and
more exposure to selective pressure due to codominant
effects versus a recessive mode of action characteristic
of trans regulation [54]. Therefore, cis eQTL could have
a predominant role in shaping genetic regulation of
transcription [55]. However, empirical evidence com-
piled from GG studies in multiples species favors the
view that trans eQTL are prevalent but show smaller
effects than cis eQTL and can be missed at low sample
sizes [6-8,56,57]. Although statistical issues related to
multiple testing of trans eQTL and power to detect
smaller effects makes it difficult to estimate the true
ratio of cis versus trans regulatory loci [55], eQTL stu-
dies in yeast [58] and Arabidopsis [59] have shown that
expression of most transcripts is most likely regulated
by multiple loci, and a study in humans showed signifi-
cant enrichment of interaction among multiple loci
affecting gene expression [57]. Therefore, we hypothe-
size that the ratio observed here is due to the small
experimental design with only four replicates per geno-
type and that the overrepresentation of candidates’
genes in congenic QTL/microarray experiments may
result from biased detection of cis eQTL as a conse-
quence of low power [9,13,14].
F2 offspring subcongenics from three congenic strains
have been assayed for the same set of biometric mea-
surements (Additional file 2) resulting in identification
of at least 13, 7, and 5 QTL on chromosomes 2, 11, and
17 respectively [60,61] (Figure 3 and Additional file 3).
The large number and overlap of QTL intervals would
make it impossible to test for co-localization between
differentially expressed genes and QTL. Instead, we
tested whether the probability of differential expression
was homogeneous along donor regions, conditioned on
the number of expressed genes in bins of 2 Mb. A Fish-
er’s exact test (see Methods) revealed no significant
departure from homogeneity for chromosome 2 (P =
0.81), 11 (P =0 . 5 2 ) ,o r1 7( P = 0.67). Inspection of Fig-
ure 3 shows that the fraction of differentially expressed
genes closely follows the distribution of genes in the
donor regions (Figure 3). These results indicate that the
distribution of selected genes within donor regions was
mostly explained by the number of expressed genes and
is not concentrated in any particular QTL region.
cis eQTL have been reported to be located preferen-
tially in non-IBD regions [15], and their regulated
genes have higher density of predicted SNP on tran-
scription binding sites [21]. Therefore, multiple authors
have proposed using the IBD status of genes to filter
or prioritize cis eQTL candidates [15,20,62]. We tested
whether genetic diversity within congenic regions was
associated with differential expression. High genomic
divergence between C57 and CAST resulted in only
14.7%, 6.4%, and 7.2% of the genes in donor regions of
chromosomes 2, 11, and 17, respectively, to be located
within IBD blocks. Using the IBD criteria discarded
only 4, 3, and 9 genes from 124, 89, and 95 cis eQTL
candidates in chromosomes 2, 11, and 17, respectively.
Overrepresentation of differentially expressed genes
within non-IBD blocks was observed only in chromo-
some 2 (P =2 . 3 5×1 0
-6)b u tn o ti nc h r o m o s o m e s1 1
Table 4 Number of differentially expressed genes outside
congenic donor regions
Chromosome Strain
HG2D HG11 HG17
12 7 0 2
21 9 0 0
33 0 2 1
42 2 1 3
52 8 0 0
63 1 0 1
73 3 0 0
83 0 1 0
92 3 3 0
10 23 1 1
11 38 9 1
12 14 3 0
13 16 0 0
14 12 1 0
15 24 0 0
16 14 0 0
17 19 0 3
1 8 800
19 22 0 0
X2 0 0 2
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Page 9 of 17(P = 0.35) or 17 (P = 0.54). Therefore, although cis
eQTL candidates were preferentially located in non-
IBD regions in agreement with Doss et al. [15], this
was not significant once the probability of any gene to
be located in IBD blocks is taken into account in chro-
mosomes 11 and 17. This indicates that in this cross
of highly divergent strains, enrichment of cis eQTLs in
these two chromosomes was driven only by the overall
higher rate of genes in those regions. This added to
the limited number of genes that would be removed
from the candidate list by the IBD criterion indicates
that there would be no real gain in using this
approach. Because we are inspecting only the chromo-
somes in one cross, we refrain from generalizing this
conclusion to other cases. However, there are four
main reason why using IBD to filter down lists of cis
eQTL candidates should be done with care. In most
cases, IBD is inferred from incomplete genotype data
originated from resequencing [63], genotype imputa-
tion [64], or microarray genotyping for SNP discovered
by the previous two methods [65]. Errors or lack of
coverage from these methods could lead to imprecision
in defining the size of IBD blocks that leads to filtering
(or not) of genes that are actually non-IBD. Second,
mutations that arose after the split of strain ancestors
are missed from imputation techniques on the basis of
a few highly divergent strains. Third, in the absence of
evidence that the strain ancestors were homozygous at
all loci, it is possible that modern strains have fixed
different alleles of functional SNP that existed as het-
erozygous SNP in the strain ancestors. Fourth, enhan-
cers in non-IBD regions may regulate expression of
g e n e st h a ta r ei nI B D .W ea r ea w a r eo fal e a s to n e
case where this would have eliminated the causal gene
if the IBD criterion were used. Prcp was identified as a
candidate gene for obesity by subcongenic isolation
and gene expression data from brain [66,67]. This gene
is located in an IBD region between the donor strains
BALB/cByJ and the background strain C57BL/6ByJ.
However, in vitro assays with recombinant PRCP
demonstrated that it has enzymatic activity to inacti-
vate a-melanocyte-stimulating hormone (a-MSH1-13)
by removing the C-terminal amino acid to produce a-
MSH1-12. a-MSH1-13, a critical anorexigenic neuromo-
dulator in the hypothalamus. A mouse model with a
gene trap in PRCP confirmed effects of PRCP on obe-
sity. In addition, inhibiting PRCP activity in vivo
decreased food intake, confirming the role of Prcp in
weight maintenance via control of active a-MSH1-13
levels [67]. Sequencing of this gene in the congenic
Figure 3 Genes selected by differential expression on chromosomes 2, 11 and 17 from congenic microarray experiments.E a c h
chromosome is shown as a vertical black bar with the IBD regions shown as horizontal gray lines along the chromosome. The olive vertical line
to the right of the chromosome represents the congenic donor region. The color bars to the left of the chromosome are the confidence
intervals of the pQTL identified in the legend. A description of the phenotypes is in Additional file 2. The total number of genes in 2 Mbp bins is
plotted in red bars to the right of the chromosomes. The number of genes in 2 Mbp bins along the chromosome is plotted with narrow
horizontal bars to the right of each chromosome: brown, total number of genes; yellow, number of genes represented in the microarray; green,
number of genes expressed in at least one tissue; blue, number of genes differentially expressed in at least one tissue. The scale labeled “Gene
counts” represents the number of genes.
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promoter C®T transition that is hypothesized to affect
the observed changes in gene expression and protein
activity, food intake, and obesity phenotypes. This SNP
was not known at that time and could not be inferred
from the parental strains’ ancestry. Therefore, identity
by descent does not imply lack of DNA polymorph-
isms and, more important, of genetic differences that
affect phenotypes.
In summary, differential expression testing in three
congenic strains revealed expression signatures enriched
for eQTL candidates, which resulted in hundreds of
genes to be considered for further testing. Expression
differences within the donor regions were distributed
according to the overall distribution of genes in those
regions and were affected by IBD blocks only on chro-
mosome 2. High genetic divergence between C57 and
CAST resulted in very limited number and size of IBD
regions. Filtering by IBD would only discard 16 genes,
which according to previous reports may well contain a
causal variant. Intense phenotyping of F2 fine mapping
populations revealed high genetic complexity, with mul-
tiple QTL, in each of these regions. The HG2D con-
genic includes multiple QTL for the same phenotype
(body weight) with opposite genotype effects [61].
Furthermore, it is possible that many more QTL would
be detected in these genomic regions if more pheno-
types were collected. From the current data, it is impos-
sible to distinguish between long-reaching linkage and
pleiotropy or to infer causal relationships between QTL,
transcripts, and organismal phenotypes. Phenotyping of
large mapping populations would be necessary to break
the association between these confounding effects.
The results from our literature review and the present
experiment do not invalidate the use of microarrays for
dissecting QTL. On the contrary, they stress the need
for new approaches to make better use of these data. It
has been shown that reanalyzing large repositories of
microarray data can identify profiles of differential
expression that are highly predictive of gene associations
to human diseases [68,69]. By ranking genes by the ratio
of experiments showing differential expression across
many conditions, Chen et al.[ 6 8 ]w e r ea b l et or e d i s -
cover disease genes with 79% specificity and 37% sensi-
tivity and proposed using this criterion to prioritize
candidates resulting from GWAS associations. More
recently, Gorlov et al. [69] found that the top genes by
differential expression between normal and cancer tissue
from human prostate are enriched for the same func-
tional categories as the top candidate genes in GWAS
and that strength of association in both tests was corre-
lated. A similar approach could be employed in model
organisms by reanalyzing results from a large number of
microarray studies in inbred and congenic strains to
increase both power and significance of genotype-phe-
notype associations. One could prioritize genes that are
repeatedly differentially expressed between mouse geno-
types that show similar phenotypic differences. Further-
more, such an approach would benefit from the
availability of dense maps of SNP by using modern sta-
tistical tools to associate phenotypes to haplotypes pro-
duced by historical recombinations while accounting for
genetic background and population structure [70].
Results from such analysis could be used to confirm and
refine the position of eQTL from GG studies using F2
or backcrosses.
Using meta-analysis of large collections of microarray
data to prioritize QTL candidates in rodents can present
several advantages over similar approaches in humans.
Linkage disequilibrium (LD) in humans can extend large
distances; it is affected by population structure and his-
tory and can even reach across multiple chromosomes
(see [71] and references therein). The situation is further
complicated in case control designs where environmen-
tal factors significantly contribute to variation in gene
expression [72]. In addition, technical factors such as
time of preparation of samples for different populations
have been proposed to explain some of the wide range
of differences in gene expression observed between Hap-
Map populations [55,73]. Environmental factors can be
more tightly controlled in experimental populations,
although differences between laboratories do have a sig-
nificant effect on microarray results and must be consid-
ered [74]. Population structure is also present in
laboratory mouse strains, and the contribution of differ-
ent lines of ancestry is unequal across different regions
of the genome [75], which would affect analyses of
expression data across multiple strains. However, new
populations can be designed to remove the effects of
population structure. One population of note is the Col-
laborative Cross [76], which promises to greatly reduce
LD and population structure (EJ Chesler, personal com-
munication), and since it will be a panel of recombinant
inbred strains, a large volume of phenotype and gene
expression data is expected to accumulate over time.
We think that these resources and the development of
better methods for data analysis will greatly improve the
success of using microarray data to dissect complex
traits in rodents.
Conclusions
A review of 37 studies from the literature that have
applied the QTL/microarray showed that this approach
is effective in reducing the list of candidate genes, with
an average proportion of 1.9% candidate genes being
differentially expressed across experiments. However, a
meta-analysis of published results showed no signifi-
cant overrepresentation of positional candidate genes
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the studies that did show enrichment of candidates
were comparisons between congenic and background
strains. Lack of standards in analytical methods for
testing differential expression testing as well as a ten-
dency to apply multiple criteria for probe selection was
observed. Our analysis showed that no increase in
enrichment is gained from this technique. In three
reviewed studies, filtering by differential expression led
to the identification of a QTG gene, where only a cou-
ple of genes were reported to be differentially
expressed [26,27,77]. However, other studies with simi-
lar filtering ratios did not have such a favorable out-
come (Table 3), and therefore luck played a role in
determining the outcome in these studies.
By performing three independent congenic microarray
experiments, we found high enrichment of genes within
donor regions among differentially expressed genes.
Within the limits of the donor regions, no clustering of
differentially expressed genes to any particular pQTL
region was observed, but a rather homogeneous distri-
bution once overall gene density is accounted for. The
high genetic divergence between C57 and CAST caused
only ~6-15% of genes in the donor regions to fall in
IBD blocks and genes within these blocks were less
likely to be differentially expressed on chromosome 2
but not on chromosomes 11 or 17. On the basis of this
and previous findings, IBD was not used to filter candi-
date genes. Furthermore, lack of genome coverage from
the microarray used and removal of probes overlapping
SNP excluded ~30% of positional candidates from differ-
ential expression testing. Overall, differential expression
testing resulted in a reduction of the number of candi-
dates by ~60-70%, leaving ~300-500 genes per donor
region that need further testing. Therefore, our power
to refine lists of candidate genes within donor regions
from microarray data was rather poor. In addition, small
sample size in our experiment restricted identification of
trans eQTL. We expect that the same is true in the
reviewed studies, contributing to the overrepresentation
of pQTL candidates in some of them, resulting in a
large number of candidates and making experimental
validation impractical.
We showed that cis eQTL can be uninformative about
QTG because they can show allelic bias toward higher
expression of the reference genome. In our data, we
found that this bias was partially explained by SNP on
the binding region of probes, but that lack of full
sequence of the CAST genome at the time of our analy-
sis did not allow complete removal of this effect. Even
with the availability of full CAST genome sequence, the
limited number of probes in the platform used restricts
the possibility of eliminating all probes matching SNP.
Methods
Collection of Microarray Studies
Compilation of studies using the QTL/microarray
approach in mice and rats was performed by retrieving
all citations that matched the Entrez query “(gene
expression OR microarray) AND (QTL OR complex
trait)” in PubMed [78], resulting in a list of 588 refer-
ences. This list was manually curated by reading titles
and abstracts and by keeping only studies that reported
original results from using microarrays to identify candi-
dates that cause differences in complex phenotypes in
mouse and rat.
Meta-analysis of QTL/Microarray studies
The analysis examined the overrepresentation or under-
representation of genes within the pQTL or target
regions that were selected in the reviewed studies. The
information relevant for the objective of this analysis
was (1) the number of genes under pQTL peaks, i.e.,
confidence limits for the position of pQTL, (2) number
of genes in the genome being represented in the micro-
arrays platform used, (3) number of differentially
expressed genes, and (4) fraction of selected genes that
are located within the confidence interval for the pQTL.
In cases where microarray profiling was performed on
congenic versus background strains, every gene located
in the donor region of the congenic strain was consid-
ered a positional candidate.
Relevant information from all studies is shown in
Tables 1 and 2 and was extracted as follows. The num-
ber of genes under a pQTL, if provided, was extracted
from the text. Otherwise, it was estimated from the
UCSC Genome Browser [79] by querying all known
genes between the flanking markers for the pQTL confi-
dence intervals; if flanking markers were not provided,
physical or genetic confidence interval limits were
obtained from the text or inferred from figures by visual
inspection. Last, if no explicit confidence limits were
plotted, a 1.5 drop in LOD from the pQTL peak was
u s e d .I fc o n f i d e n c el i m i t sw e r eo n l ya v a i l a b l ea sg e n e t i c
positions, cM were transformed to Mbp using the
results from a high-density SNP mapping experiment
[80]. For experiments on congenic strains, flanking mar-
kers of the donor regions where used. NCBI mouse gen-
ome build 37 and rat build 3.4 were used to locate
genetic markers in the physical genomic coordinates.
The results of data collection are summarized in Table
3. The numbers of candidate genes in Table 3 are the
totals for all pQTL considered in each study and should
be regarded as approximate estimates of the real
numbers.
Significance of over or under representation of pQTL
candidate genes was assessed by a Fisher’s exact test
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Ho :
candidate genes
genes in reference set
selected candidat
=
e e genes
selected genes
,
where “candidate genes” refers to genes located within
pQTL confidence intervals or donor congenic regions
(depending on the experimental design of the microar-
ray experiment), “genes in reference set” is the total
number of genes considered, “selected candidate genes”
is the number of genes differentially expressed in the
candidate region, and “selected genes” is the total num-
ber of differentially expressed genes. In other words,
under the null hypothesis, the detection of differentially
expressed genes is assumed as a process of randomly
sampling genes from a pool that includes genes within
and outside the target region. Therefore, the fraction of
target genes in the selected sample is expected to be
equal to the fraction in the gene set that is used as a
reference. The ratio of these two ratios is called the
Ratio of Odds (OddsRatio). A Fisher’se x a c tt e s tf o r
overrepresentation (OddsRatio > 1) or underrepresenta-
tion (OddsRatio < 1) of candidate genes in the list of
differentially expressed genes was performed and P
values were calculated from the hypergeometric distri-
bution by using the fisher.test function in R. Two over-
representation tests were performed by either using the
total number of genes in the genome or the number of
probes in the microarray. The number of genes in the
genome was obtained from the assembly statistics at the
Ensembl genome browser [81,82] by adding counts for
“Known protein-coding,”“ Projected protein-coding,”
and “Novel protein-coding” gene categories (26,404 M.
musculus genes, Build 37; 22,503 R. norvegicus genes,
B u i l d3 . 4 ) .T h es e c o n dt e s t ,u s i n gn u m b e ro fp r o b e si n
the microarray, is intended to control for the effect of
different levels of genome coverage by microarrays. An
ideal reference would only consider genes that are
included in the microarrays. However, because of non-
existent or obsolete annotations for some platforms, this
information is not always known and we used the total
number of probesets as an approximation.
Experiment using three congenic strains
Three congenic mouse strains were profiled with micro-
arrays and were analyzed using a QTL/microarray
approach to identify candidate genes that regulate obe-
sity traits: HG2D (HG.CAST-(D2Mit329-D2Mit457)),
HG11 (HG.CAST-(D11Mit260-D11Mit255, MGI refer-
ence: 3771218), and HG17 (HG.CAST-(D17Mit196-
D17Mit190); MGI reference: 3771215) [53]. All these
congenic strains isolate CAST/EiJ (CAST) alleles in a
C57BL/6J
hg/hg (C57) background and bare the hg
deletion in the high growth locus on chromosome 10
[83,84]. Animals for microarray profiling were generated
from an F2 intercross between congenic males and
C57BL/6J control females. Mice were weaned at 3 weeks
old, housed in age- and sex-matching cages with five or
fewer animals per cage. All animals were fed a standard
Purina Formulab Chow 5008 diet and killed at 9 weeks
old. Nonrecombinant animals for the congenic region
that were homozygous for congenic or background
alleles and hg/hg for the high growth locus were selected.
Brain, liver, and gonadal white adipose tissues were col-
lected from four biological replicates, snap frozen in
liquid nitrogen, and stored at -80°C. All samples were
obtained from males except for adipose tissue in HG2D.
All mouse protocols followed the guidelines of the
American Association for Accreditation of Laboratory
Animal Care [85].
RNA was purified, prepared, and hybridized using
manufacturers’ protocols. Briefly, total RNA was
extracted with TRIzol reagent (Invitrogen, Carlsbad,
CA), DNase treated (TurboDNA, Ambion Inc., Austin,
TX), and cDNA was generated by reverse transcription
using Total Prep RNA Amplification Kit (Illumina Inc.,
San Diego, CA). cDNA was labeled with Biotin-16-UTP
and hybridized to Mouse-6 V1 Illumina BeadArrays at
t h eG e n eE x p r e s s i o nC o r ef a c i l i t yo ft h eU n i v e r s i t yo f
California Davis Genome Center (Davis, CA). BeadAr-
rays were scanned and features were extracted using
BeadStudio V. 1.5.1.3 (Illumina Inc., San Diego, CA).
Local background correction was done at scanning
using default values. Bead level data was summarized by
removing outliers greater than 3 median absolute devia-
tions (MADs) from the median and by calculating the
mean and variance of the remaining beads. Summarized
intensity values were imported into the R 2.9.2 lan-
guage/environment for normalization and analysis [86].
The probes in Mouse-6 array were gene-annotated in-
house to ensure current coverage of the mouse genome.
Probe sequences were aligned to the mm9 mouse gen-
ome (Genome Build 37) obtained from the UCSC Gen-
ome Browser [87]. Sequence alignment was performed
with stand-alone BLAT [88]. Probes mapping to multi-
ple locations or with gaps larger than 10 Kb were not
annotated. The resulting alignments were overlaid to, in
this order, NCBI’s RefSeqs [89], mouse mRNA, and
human proteins mapped to the mouse genome by
UCSC [79]. Intensity values were normalized with a
quantiles the affy package from Bioconductor [90].
Probes were filtered by present calls (P <0 . 0 1 )i nf o u r
or more samples from any given tissue. A total of 72
samples (3 strains × 2 genotypes × 3 tissue × 4 repli-
cates) were hybridized to 12 Mouse-6 chips. Differential
expression was tested by fitting a cell-means linear
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single-sample intensity values,
yij i ij =+ +   ,
where yij is the base 2 log transformed gene expres-
sion, μ is the overall mean, μi is the effect of experimen-
tal group k (k = 1,...,18), and εij is the residual effect (j =
1,...,4). Experimental group was defined as the combina-
tion of strain, genotype within strain, and tissue. For
each strain, there are six experimental groups: B.B, B.C,
F.B, F.C, L.B, and L.C, where the first letter indicates tis-
sue (B = brain, F = fat, and L = liver) and the second
letter is genotype (B = C57 and C = CAST). Differential
expression by genotype was tested by the following con-
trasts: L.Geno = L.C-L.B, F.Geno = F.C-F.B, and B.Geno
= B.C-B.B. Model fitting and contrasts testing was done
with the R/Maanova software [91]. F values were calcu-
lated with James-Stein shrinkage estimates of the error
variance [92]. P values were calculated by 1000 permuta-
tions of sample labels and by pooling permutation F
values across probes. Multiple comparison error was
controlled by a false discovery rate (FDR) transformation
[93]. Probe with a FDR <10% for any tissue were
selected.
Over- or underrepresentation of positional candi-
dates in the set of differentially expressed genes was
tested by Fisher’s exact test as described above for
meta-analysis of literature results. For the test of
homogeneity or rations of differentially expressed
genes along donor regions, P values were estimated by
sampling 2 million Monte Carlo simulations of the
possible contingency tables using the fisher.test Rf u n c -
tion. Probes targeting transcripts associated to the
same EntrezGenes were grouped so that overrepresen-
tation tests counted genes as selected if any of their
transcripts were found differentially expressed. Probes
within the congenic regions that overlapped at least
one SNP from between C57 and CAST were not con-
sidered [64]. Significance was determined from a Fish-
er’s exact test (a = 0.05) as described above. Every
gene within the limits of the donor regions of the con-
genic strains was considered a candidate. A similar test
was done for genes from non-IBD regions that were
selected as differentially expressed. IBD blocks for
chromosomes 2, 11, and 17 were inferred from a data-
base of imputed genotypes [64] and downloaded from
the CGD Strain Comparison web tool [94]. IBD
regions were identified as contiguous blocks of 10 Kbp
with 10 or more uninformative SNP between the C57
and CAST strains. Genes were considered in IBD
regions if both the transcription start and end sites
were located within IBD block boundaries.
Additional material
Additional file 1: Metadata from QTL/Microarray Studies in Rat and
Mouse. Table with one row per each of 37 reviewed studies
implementing the QTL/Microarray approach in rodents. Information
about experimental design and results was collected. Additional sheets
contain description of acronyms and the full list of references.
Additional file 2: List of phenotypes measured in three congenic
strains HG2D, HG11, HG17. The file contains a list, symbol and units of
measurement for 16 phenotypes measured in the mice.
Additional file 3: QTL located within the limits of the donor regions
for the HG2D, HG11, and HG17 congenic strains. The file contains a
table with interval limits representing a non-redundant set of QTL from
the cited references at the highest resolution currently known.
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